Early research (Phase 1)UnknownNCT01337310What this trial is testingStudy of Tesetaxel in Japanese Patients With Solid TumorsWho this might be right forAdvanced Solid Tumors Genta Incorporated 12
Early research (Phase 1)Study completedNCT00412997What this trial is testingLBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell LymphomaWho this might be right forTumorsCutaneous T-Cell Lymphoma Novartis 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318What this trial is testingTR115 in ARID1A-Mutated Advanced Solid TumorsWho this might be right forOvarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more Tarapeutics Science Inc. 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06220318What this trial is testingAssessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid TumorsWho this might be right forSolid Tumor Fujian Haixi Pharmaceuticals Co., Ltd. 155
Testing effectiveness (Phase 2)Study completedNCT02335918What this trial is testingA Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid TumorsWho this might be right forSquamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more Celldex Therapeutics 175
Early research (Phase 1)Study completedNCT01170897What this trial is testingStudy of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Halozyme Therapeutics 27
Early research (Phase 1)Study completedNCT04808453What this trial is testingPhase I Study of CPI-300 in Patients With Advanced TumorsWho this might be right forAdvanced Tumors Coordination Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Looking for participantsNCT07296341What this trial is testingHRS-4642 Combination With Other Antitumor Therapies in Patients With Solid TumorsWho this might be right forLocally Advanced or Metastatic Pancreatic Cancer With Shanghai Hengrui Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Ended earlyNCT06540066What this trial is testingBGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced CancerAdvanced Solid TumorMetastatic Cancer+1 more BeiGene 35
Early research (Phase 1)Looking for participantsNCT06686745What this trial is testingStudy of SIM0508 Alone and in Combination in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Testing effectiveness (Phase 2)Looking for participantsNCT06293651What this trial is testingClinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors Dong-A ST Co., Ltd. 125
Early research (Phase 1)Study completedNCT00773929What this trial is testingSafety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced CancerWho this might be right forSolid Tumors Millennium Pharmaceuticals, Inc. 60
Early research (Phase 1)Study completedNCT05277402What this trial is testingADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid TumorsWho this might be right forAdvanced/Metastatic Solid Tumors Adagene Inc 6
Early research (Phase 1)Ended earlyNCT05061537What this trial is testingStudy of PF-07263689 in Participants With Selected Advanced Solid TumorsWho this might be right forRenal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more Pfizer 13
Early research (Phase 1)Study completedNCT01975831What this trial is testingEvaluate MEDI4736 in Combination With TremelimumabWho this might be right forBreast CancerOvarian CancerColorectal Cancer+2 more Ludwig Institute for Cancer Research 104
Early research (Phase 1)Study completedNCT03733951What this trial is testingKN046 in Subjects With Advanced Solid Tumors and LymphomaWho this might be right forAdvanced Solid TumorsLymphoma Jiangsu Alphamab Biopharmaceuticals Co., Ltd 139
Testing effectiveness (Phase 2)Ended earlyNCT05169437What this trial is testingNiraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsWho this might be right forSolid TumorBreast TumorColon Tumor, Malignant+9 more Tempus AI 22
Early research (Phase 1)Study completedNCT01966445What this trial is testingDose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid TumorsWho this might be right forCancerNeoplasms GlaxoSmithKline 29
Early research (Phase 1)Ended earlyNCT06466187What this trial is testingSGN-MesoC2 in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more Seagen, a wholly owned subsidiary of Pfizer 19
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06992687What this trial is testingEvaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumors Shanghai Huaota Biopharmaceutical Co., Ltd. 30